Typically, candidates for tirzepatide for weight loss include: Adults with a body mass index (BMI) of 30 kg/m or greater (classified as obesity) Adults with a BMI of 27 kg/m or greater who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol Tirzepatide is not intended for individuals with a personal or family history of medullary thyroid carcinoma, those with multiple endocrine neoplasia syndrome type 2, or anyone with a known hypersensitivity to the medication
Nausea, the most commonly reported side effect, typically peaks during the first 24 weeks of treatment or after dose increases, then gradually diminishes as your body adapts to the medication
A dietitian can help you choose nutrient-rich foods you enjoy, plan meals that fit your smaller appetite, and suggest ways to manage side effects (like which foods to eat when feeling nauseous)
The concentration must align with the syringes measurement increments, usually insulin syringes marked in units
However, household freezers experience frequent temperature swings from door use and automatic defrost cycles
What matters is that both trials, in different populations and different durations, produced nearly identical efficacy results